Precision medicine in oncology: what is it exactly and where are we?

被引：6
|
作者：
Le Tourneau, Christophe [1 ,2 ,3 ,4 ]
Kamal, Maud [1 ,2 ]
Bieche, Ivan [5 ]
机构：
[1] Inst Curie, Dept Drug Dev & Innovat, Paris, France
[2] Inst Curie, Dept Drug Dev & Innovat, St Cloud, France
[3] Inst Curie, INSERM, Res Unit, U900, St Cloud, France
[4] Versailles St Quentin En Yvelines Univ, Oncol Univ Dept, Montigny Le Bretonneux, France
[5] Inst Curie, Pharmacogenom Unit, Paris, France
来源：
PERSONALIZED MEDICINE | 2018年 / 15卷 / 05期
关键词：
immunotherapy; oncology; precision medicine; predictive biomarker; prognostic biomarker; sequencing; SHIVA01; targeted therapy; PERSONALIZED MEDICINE; ADVANCED CANCER; PD-1; BLOCKADE; VALIDATION; PROGRAM;
D O I：
10.2217/pme-2018-0036
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
[No abstract available]
引用
收藏
页码：351 / 353
页数：3
相关论文
共 50 条
  • [1] Perioperative Precision Medicine: Where Are We in 2020?
    Pal, Nirvik
    Kertai, Miklos D.
    CURRENT OPINION IN ANESTHESIOLOGY, 2020, 33 (03) : 463 - 474
  • [2] Translational Research in the Era of Precision Medicine: Where We Are and Where We Will Go
    De Maria Marchiano, Ruggero
    Di Sante, Gabriele
    Piro, Geny
    Carbone, Carmine
    Tortora, Giampaolo
    Boldrini, Luca
    Pietragalla, Antonella
    Daniele, Gennaro
    Tredicine, Maria
    Cesario, Alfredo
    Valentini, Vincenzo
    Gallo, Daniela
    Babini, Gabriele
    D'Oria, Marika
    Scambia, Giovanni
    JOURNAL OF PERSONALIZED MEDICINE, 2021, 11 (03):
  • [3] Precision medicine and pharmacogenetics: what does oncology have that addiction medicine does not?
    Kranzler, Henry R.
    Smith, Rachel V.
    Schnoll, Robert
    Moustafa, Afaf
    Greenstreet-Akman, Emma
    ADDICTION, 2017, 112 (12) : 2086 - 2094
  • [4] Precision medicine in cardiac electrophysiology: where we are and where we need to go
    Correa, Ashish
    Haider, Syed Waqas
    Aronow, Wilbert S.
    EXPERT REVIEW OF PRECISION MEDICINE AND DRUG DEVELOPMENT, 2020, 5 (03): : 165 - 180
  • [5] Personalized medicine in oncology: where have we come from and where are we going?
    Andre, Fabrice
    Ciccolini, Joseph
    Spano, Jean-Philippe
    Penault-Llorca, Frederique
    Mounier, Nicolas
    Freyer, Gilles
    Blay, Jean-Yves
    Milano, Gerard
    PHARMACOGENOMICS, 2013, 14 (08) : 931 - 939
  • [6] Precision Medicine for Metastatic Colorectal Cancer: Where Do We Stand?
    Underwood, Patrick W.
    Pawlik, Timothy M.
    CANCERS, 2024, 16 (22)
  • [7] Precision medicine strategies in oncology: mixed approaches to matched therapies
    Borcoman, Edith
    Le Tourneau, Christophe
    FUTURE ONCOLOGY, 2018, 14 (02) : 105 - 109
  • [8] Clinical RNA sequencing in oncology: where are we?
    Pedersen, Gitte
    Kanigan, Tanya
    PERSONALIZED MEDICINE, 2016, 13 (03) : 209 - 213
  • [9] Precision Medicine:What Challenges Are We Facing?
    Yu Xue
    Eric-Wubbo Lameijer
    Kai Ye
    Kunlin Zhang
    Suhua Chang
    Xiaoyue Wang
    Jianmin Wu
    Ge Gao
    Fangqing Zhao
    Jian Li
    Chunsheng Han
    Shuhua Xu
    Jingfa Xiao
    Xuerui Yang
    Xiaomin Ying
    Xuegong Zhang
    Wei-Hua Chen
    Yun Liu
    Zhang Zhang
    Kun Huang
    Jun Yu
    Genomics,Proteomics & Bioinformatics, 2016, (05) : 253 - 261
  • [10] Moving towards Personalized Medicine in Muscle-Invasive Bladder Cancer: Where Are We Now and Where Are We Going?
    Pardo, Juan Carlos
    de Porras, Vicenc Ruiz
    Plaja, Andrea
    Carrato, Cristina
    Etxaniz, Olatz
    Buisan, Oscar
    Font, Albert
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2020, 21 (17) : 1 - 13
12345